Showing results (111-120 of 164) with videos related to

Sort By:
Pageof 17
Molecular Oncology|October 6, 2023
Expanding a precision medicine platform for malignant peripheral nerve sheath tumors: New patient-derived orthotopic xenografts, cell lines and tumor entitiesEdgar Creus-Bachiller, Juana Fernández-Rodríguez, Miriam Magallón-Lorenz, et al.
Cancers|October 17, 2020
High Cysteinyl Leukotriene Receptor 1 Expression Correlates with Poor Survival of Uveal Melanoma Patients and Cognate Antagonist Drugs Modulate the Growth, Cancer Secretome, and Metabolism of Uveal Melanoma CellsKayleigh Slater, Aisling B Heeran, Sandra Garcia-Mulero, et al.
Molecular Oncology|April 21, 2023
CDK6 is activated by the atypical cyclin I to promote E2F-mediated gene expression and cancer cell proliferationEva Quandt, Núria Masip, Sara Hernández-Ortega, et al.
JCI Insight|August 8, 2020
Inhibition of DDR1 enhances in vivo chemosensitivity in KRAS-mutant lung adenocarcinomaMarie-Julie Nokin, Elodie Darbo, Camille Travert, et al.
EMBO Molecular Medicine|March 27, 2015
Comprehensive establishment and characterization of orthoxenograft mouse models of malignant peripheral nerve sheath tumors for personalized medicineJoan Castellsagué, Bernat Gel, Juana Fernández-Rodríguez, et al.
Cell Stem Cell|May 13, 2020
Zonation of Ribosomal DNA Transcription Defines a Stem Cell Hierarchy in Colorectal CancerClara Morral, Jelena Stanisavljevic, Xavier Hernando-Momblona, et al.
Molecular Cancer Therapeutics|May 5, 2022
A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath TumorsJuana Fernández-Rodríguez, Edgar Creus-Bachiller, Xiaohu Zhang, et al.
Therapeutic Advances in Medical Oncology|July 17, 2020
Use of patient derived orthotopic xenograft models for real-time therapy guidance in a pediatric sporadic malignant peripheral nerve sheath tumorJuana Fernández-Rodríguez, Andrés Morales La Madrid, Bernat Gel, et al.
Elife|October 22, 2025
Chromatin activity of IκBα mediates the exit from naïve pluripotencyLuis G Palma, Daniel Alvarez-Villanueva, Maria Maqueda, et al.
Nature Communications|July 15, 2021
SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockadeOctavio A Romero, Andrea Vilarrubi, Juan J Alburquerque-Bejar, et al.
Pageof 17